JP2025146838A5 - - Google Patents

Info

Publication number
JP2025146838A5
JP2025146838A5 JP2025101407A JP2025101407A JP2025146838A5 JP 2025146838 A5 JP2025146838 A5 JP 2025146838A5 JP 2025101407 A JP2025101407 A JP 2025101407A JP 2025101407 A JP2025101407 A JP 2025101407A JP 2025146838 A5 JP2025146838 A5 JP 2025146838A5
Authority
JP
Japan
Prior art keywords
seq
sequence
cdr
administration
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025101407A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025146838A (ja
Filing date
Publication date
Priority claimed from PCT/CA2019/051823 external-priority patent/WO2020118458A1/en
Application filed filed Critical
Publication of JP2025146838A publication Critical patent/JP2025146838A/ja
Publication of JP2025146838A5 publication Critical patent/JP2025146838A5/ja
Pending legal-status Critical Current

Links

JP2025101407A 2018-12-14 2025-06-17 ミスフォールドtdp-43に対する抗体およびその使用方法 Pending JP2025146838A (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201862779904P 2018-12-14 2018-12-14
US62/779,904 2018-12-14
US201962923789P 2019-10-21 2019-10-21
US62/923,789 2019-10-21
PCT/CA2019/051823 WO2020118458A1 (en) 2018-12-14 2019-12-16 Antibodies to misfolded tdp-43 and methods of use
JP2021533492A JP7829171B2 (ja) 2018-12-14 2019-12-16 ミスフォールドtdp-43に対する抗体およびその使用方法

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2021533492A Division JP7829171B2 (ja) 2018-12-14 2019-12-16 ミスフォールドtdp-43に対する抗体およびその使用方法

Publications (2)

Publication Number Publication Date
JP2025146838A JP2025146838A (ja) 2025-10-03
JP2025146838A5 true JP2025146838A5 (enExample) 2026-05-13

Family

ID=71076680

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021533492A Active JP7829171B2 (ja) 2018-12-14 2019-12-16 ミスフォールドtdp-43に対する抗体およびその使用方法
JP2025101407A Pending JP2025146838A (ja) 2018-12-14 2025-06-17 ミスフォールドtdp-43に対する抗体およびその使用方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2021533492A Active JP7829171B2 (ja) 2018-12-14 2019-12-16 ミスフォールドtdp-43に対する抗体およびその使用方法

Country Status (6)

Country Link
US (1) US12559548B2 (enExample)
EP (1) EP3894433A4 (enExample)
JP (2) JP7829171B2 (enExample)
AU (1) AU2019399680B2 (enExample)
CA (1) CA3123116A1 (enExample)
WO (1) WO2020118458A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230003067A (ko) * 2020-04-29 2023-01-05 더 유니버시티 오브 브리티쉬 콜롬비아 미스폴딩된 tdp-43에 대한 단일쇄 항체 및 인트라바디 그리고 사용 방법
CA3231484A1 (en) 2021-10-01 2023-04-06 Qinwen Mao Pathologic tdp-43 as a biomarker for the diagnosis of tdp-43 proteinopathy
IL316153A (en) * 2022-04-08 2024-12-01 Ac Immune Sa Anti-tdp-43 binding molecules
EP4497826A4 (en) 2022-04-22 2026-03-25 Univ Niigata TDP-43 AGGREGATION SUPPRESSANT AND PHARMACEUTICAL COMPOSITION
AU2024403128A1 (en) * 2023-12-19 2026-06-25 Vectory Therapeutics B.V. Anti-tdp-43 antibodies and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7910703B2 (en) 2006-03-10 2011-03-22 Zymogenetics, Inc. Antagonists to IL-17A, IL-17F, and IL-23P19 and methods of use
CA2853412C (en) * 2011-10-28 2021-05-04 University Of Zurich Tdp-43 specific binding molecules
JP2018503596A (ja) 2014-10-03 2018-02-08 アカデミア シニカAcademia Sinica Tdp−43の病理学的形態に対する抗体及びその使用
WO2018226590A1 (en) 2017-06-05 2018-12-13 The Trustees Of Columbia University In The City Of New York Peptides as biomarkers in the diagnosis, confirmation and treatment of a neurological disorder and immunoprofiling in neurodegenerative disease

Similar Documents

Publication Publication Date Title
JP7532571B2 (ja) 抗N3pGluアミロイドベータペプチド抗体およびその使用
JP7620807B2 (ja) 抗SIRPα抗体およびその適用
CA3133508A1 (en) Bispecific antibody specifically bound to vegf and ang2
JP2019507580A5 (enExample)
JP7829171B2 (ja) ミスフォールドtdp-43に対する抗体およびその使用方法
JP2019505166A5 (enExample)
CN109721656B (zh) 靶向rankl的治疗性抗体
WO2020123330A2 (en) Anti-alpha-synuclein antibodies and uses thereof
WO2019230856A1 (ja) Nav1.7モノクローナル抗体
CN113227148A (zh) 抗gpc3抗体、其抗原结合片段及其医药用途
AU2023382738A1 (en) Anti-papp-a antibodies and methods of use thereof
JP7457880B2 (ja) 新規なNav1.7モノクローナル抗体
WO2024225446A1 (ja) 新規なNav1.7モノクローナル抗体を含む医薬組成物
WO2025086564A1 (zh) 抗人vsig4的抗体及其医药用途
CN114174343A (zh) 双特异性抗体
US20240392001A1 (en) Lilrb2-specific monoclonal antibodies and methods of their use
US20230242673A1 (en) Anti-pcsk9 antibody and use thereof
JPWO2019054460A1 (ja) 抗ramp2抗体
HK40110725A (en) Novel nav1.7 monoclonal antibody
EP4396226A2 (en) Monospecific and bispecific antibodies and antigen binding fragments thereof
CN118119711A (zh) 新的Nav1.7单克隆抗体
HK40049006A (en) Anti-gpc3 antibody, antigen-binding fragment thereof, and medical use thereof
HK40049006B (en) Anti-gpc3 antibody, antigen-binding fragment thereof, and medical use thereof
HK40036076A (en) Anti-trop-2 antibody, antigen binding fragment thereof and medical use thereof
HK40069431A (en) Bispecific antibody